Opportunity overview
This funding will support the Dermatology Get It Right First Time programme (GIRFT) by providing: • Clinical advice and leadership to identify unwarranted clinical variation in the delivery of their specialty at regional, system, place, and provider level. • Clinical advice and leadership to identify best practice standards across the speciality. • Clinical advice and leadership on the development of appropriate clinical data/metrics to underpin continuous improvement and achievement across the specialty. • Support for the creation of national reports, recommendations and clinical products. The effective date for this modification is 01/04/25 and the value is £76,000. There is no change in contract dates or term which remains remains 1 April 2022 - 31 March 2030, inclusive of 3 year option to extend.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
- Contract value
- £4.5bn
- Awarded
- Not supplied
- Contract signed
- 31 Mar 2022
- Award ID
- 025282-2026-2099 /S 001-999999-1
- Status
- active
- Identifier
- GB-NHS RM1
- Location
- Norwich, UKH15, United Kingdom
Classification
- CPV85110000 — Hospital and related services
Lots
- This funding will support the Dermatology Get It Right First Time programme (GIRFT) by providing: • Clinical advice and leadership to identify unwarranted clinical variation in the delivery of their specialty at regional, system, place, and provider level. • Clinical advice and leadership to identify best practice standards across the speciality. • Clinical advice and leadership on the development of appropriate clinical data/metrics to underpin continuous improvement and achievement across the specialty. • Support for the creation of national reports, recommendations and clinical products. The effective date for this modification is 01/04/25 and the value is £76,000. There is no change in contract dates or term which remains remains 1 April 2022 - 31 March 2030, inclusive of 3 year option to extend.Value not stated